Towards a global human embryonic stem cell bank

American Journal of Bioethics

Volumn 7, Issue 8, 2007, Pages 37-44

  Lott, Jason P ^a   Savulescu, Julian ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Banking; Bioethics; Immunology; Organs; Stem cells; Transplantation

Indexed keywords

EPITOPE; HISTOCOMPATIBILITY ANTIGEN;

BIOETHICS; CELL NUCLEUS TRANSPLANTATION; CLONING; DONOR; ECONOMICS; EMBRYONIC STEM CELL; ETHICS; FERTILIZATION IN VITRO; HAPLOTYPE; HEALTH; HEALTH CARE COST; HEALTH CARE FACILITY; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; MOTIVATION; ORGAN TRANSPLANTATION; ORGANIZATION AND MANAGEMENT; REVIEW; SOCIAL PSYCHOLOGY; TRANSPLANTATION; UNITED KINGDOM;

BIOETHICAL ISSUES; CLONING, ORGANISM; EMBRYONIC STEM CELLS; EPITOPES; FERTILIZATION IN VITRO; GREAT BRITAIN; HAPLOTYPES; HEALTH CARE COSTS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MOTIVATION; NUCLEAR TRANSFER TECHNIQUES; ORGAN TRANSPLANTATION; PREJUDICE; TISSUE AND ORGAN PROCUREMENT; TISSUE BANKS; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; WORLD HEALTH;

EID: 34548071972     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160701462426     Document Type: Review

References (27)

1. Blyth, E. 2002. Subsidized IVF: The development of 'egg sharing' in the United Kingdom. Human Reproduction 17(12): 3254-3259.
2. Bok, H., K. E. Schill, and R. R. Faden. 2004. Justice, ethnicity, and stem cell banks. Lancet 364(9429): 118-121.
3. Bradley, J. A., E. M. Bolton, and R. A. Pedersen. 2002. Stem cell medicine encounters the immune system. Nature Reviews Immunology 2(11): 859-871.
4. Cooper, D. K. C., and R. P. Lanza. 2000. XENO: The promise of transplanting animal organs into humans. Oxford, UK: Oxford University Press.
5. Council for International Organizations of Medical Sciences. 2002. International ethical guidelines for biomedical research involving human subjects. Geneva, CH: CIOMS.
6. Dash, S. C., and S. K. Agarwal. 2006. Incidence of chronic kidney disease in India. Nephrology Dialysis Transplantation 21(1): 232-233.
7. Dirks, J. 2005. A world perspective on renal care: The challenges of prevention and treatment. European Dialysis and Transplant Nurses Association-European Renal Care Association Journal 31(2): 72-74.
8. Erin, C. A., and J. Harris. 2003. An ethical market in human organs. Journal of Medical Ethics 29(3): 137-138.
9. Faden, R. R., L. Dawson, A. S. Bateman-House, B. Philosophe, E. J. Schweitzer, et al. 2003. Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Center Report 33(6): 13-27.
10. Foster, C. E., 3rd, et al. 2002. A decade of experience with renal transplantation in African-Americans. Annals of Surgery 236(6): 794-804.
11. Harris, J. 2003a. Organ procurement: Dead interests, living needs. Journal of Medical Ethics 29(3): 130-134.
12. Harris, J. 2003b. Stem cells, sex, and procreation. Cambridge Quarterly Healthcare Ethics 12(4): 353-371.
13. Healy, L., C. Hunt, L. Young, and G. Stacey. 2005. The UK Stem Cell Bank: Its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines. Advanced Drug Delivery Review 57(13): 1981-1988.
14. Hoffman, D. I., G. L. Zellman, C. C. Fair, et al. 2003. Cryopreserved embryos in the United States and their availability for research. Fertility and Sterility 79(5): 1063-1069.
15. Hussain, M. A., and N. D. Theise. 2004. Stem-cell therapy for diabetes mellitus. Lancet 364(9429): 203-205.
16. Jain, T. 2006. Socioeconomic and racial disparities among infertility patients seeking care. Fertility Science 85(4): 876-881.
17. Jiang, Y., B. N. Jahagirdar, R. L. Reinhardt, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893): 41-49.
18. McKenna, R. M., K. R. Lee, J. C. Gough, et al. 1998. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation 66(1): 38-43.
19. McKenna, R. M., and S. K. Takemoto. 2000. Improving HLA matching for kidney transplantation by use of CREGs. Lancet 355(9218): 1842-1843.
20. Savulescu, J. 2001a. Procreative beneficence: Why we should select the best children. Bioethics. 15(5-6): 413-426.
21. Savulescu, J. 2001b. Taking the plunge. New Scientist 169: 50.
22. Savulescu, J., and J. Harris. 2004. The creation lottery: Final lessons from natural reproduction: Why those who accept natural reproduction should accept cloning and other Frankenstein reproductive technologies. Cambridge Quarterly Healthcare Ethics 13(1): 90-95.
23. Schieve, L. A., H. B. Peterson, S. F. Meikle, et al. 1999. Live-birth rates and multiple-birth risk using in vitro fertilization. Journal of the American Medical Association 282(19): 1832-1838.
24. St. John, J. C., and J. Alderson. 2005. Stem-cell banking: The size of the task. Lancet 366(9502): 1991-1992.
25. Takemoto, S., P. I. Terasaki, D. W. Gjertson, and J. M. Cecka. 1994. Equitable allocation of HLA-compatible kidneys for local pools and minorities. New England Journal of Medicine 331(12): 760-764.
26. Taylor, C. J., E. M. Bolton, S. Pocock, L. D. Sharples, R. A. Pedersen, and J. A. Bradley. 2005. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366(9502): 2019-2025.
27. Thorsby, E., P. Pfeffer, and T. Leivestad. 2004. Role of HLA molecules in the induction of alloimmune responses: Clinical significance in the cyclosporine era. Transplantation Proceedings 36(2 Suppl): 16S-21S.